Pfizer Inc. financials

  1. Home
  2. Financials
  3. PFE
PFE CIK 0000078003

Source: EDGAR filings · Built 2026-06-02T03:49:26Z

Custom taxonomy namespace: ffd

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Free Cash Flow 9.07B 9.84B 4.79B 26.03B 29.87B 12.18B
Working Capital 5.91B 7.36B -4.46B 9.12B 17.02B 9.15B
Net Debt 66.27B 65.96B 72.31B 38.63B 39.45B 39.48B
Gross Margin 74.33% 71.94% 50.99% 62.59% 58.14% 79.63%
Net Margin 12.42% 12.62% 4.16% 34.18% 29.85% 21.99%
Return on Equity (ROE) 8.99% 9.11% 2.38% 32.80% 28.47% 14.48%
Return on Assets (ROA) 3.73% 3.76% 0.94% 15.91% 12.11% 5.94%
Current Ratio 1.16× 1.17× 0.91× 1.22× 1.40× 1.35×
Debt-to-Equity 0.78× 0.76× 0.84× 0.41× 0.54× 0.65×
Effective Tax Rate -3.54% -0.35% -105.39% 9.58% 7.62% 5.26%
Cash Conversion Ratio 1.51× 1.59× 4.11× 0.93× 1.48× 1.57×
Accruals Ratio -0.02× -0.02× -0.03× 0.01× -0.06× -0.03×
SBC % of Revenue 1.28% 1.38% 1.03% 0.95% 1.61% 1.81%
CapEx Coverage 4.45× 4.38× 2.23× 9.04× 12.02× 6.47×
Free Cash Flow Per Share $1.59 $1.73 $0.84 $4.54 $5.23 $2.16

Valuation Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
P/E Trailing (Diluted) 18.31× 18.82× 77.81× 9.37× 15.34× 22.58×
P/FCF 15.68× 15.38× 34.29× 11.28× 11.28× 17.03×
FCF Yield 6.38% 6.50% 2.92% 8.86% 8.86% 5.87%
P/S 3.83× 4.00× 5.41× 5.31× 7.59× 8.31×
P/B 2.77× 2.89× 3.09× 5.10× 7.24× 5.48×

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenue from Contract with Customer, Excluding Assessed Tax — — 50.91B 91.79B 73.64B 41.65B
Revenues 62.58B 63.63B 59.55B 101.17B 81.29B 41.65B
Cost of Goods and Services Sold 16.07B 17.85B 24.95B 34.34B 30.82B 8.48B
Selling, General and Administrative Expense 13.79B 14.73B 14.77B 13.68B 12.70B 11.60B
Income Tax Expense (Benefit) -266.00M -28.00M -1.11B 3.33B 1.85B 370.00M
Net Income (Loss) Attributable to Parent 7.77B 8.03B 2.12B 31.37B 21.98B 9.16B
Earnings Per Share, Basic $1.37 $1.42 $0.38 $5.59 $3.92 $1.65
Weighted Average Number of Shares Outstanding, Basic 5.68B 5.66B 5.64B 5.61B 5.60B 5.55B
Earnings Per Share, Diluted $1.36 $1.41 $0.37 $5.47 $3.85 $1.63
Weighted Average Number of Shares Outstanding, Diluted 5.71B 5.70B 5.71B 5.73B 5.71B 5.63B

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash and Cash Equivalents, at Carrying Value 1.14B 1.04B 2.85B 416.00M 1.94B 1.79B
Assets, Current 42.90B 50.36B 43.33B 51.26B 59.69B 35.07B
Assets 208.16B 213.40B 226.50B 197.21B 181.48B 154.23B
Long-term Debt — — — — — 4.00B
Liabilities, Current 36.98B 42.99B 47.79B 42.14B 42.67B 25.92B
Long-term Debt, Excluding Current Maturities 61.64B 57.41B 61.54B 32.88B 36.20B 37.13B
Liabilities 121.39B 124.90B 137.21B 101.29B 104.01B 90.76B
Stockholders' Equity Attributable to Parent 86.48B 88.20B 89.01B 95.66B 77.20B 63.24B

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities 11.70B 12.74B 8.70B 29.27B 32.58B 14.40B
Payments to Acquire Property, Plant, and Equipment 2.63B 2.91B 3.91B 3.24B 2.71B 2.23B
Net Cash Provided by (Used in) Investing Activities -1.35B 2.65B -32.28B -15.78B -22.55B -4.27B
Payments for Repurchase of Common Stock — 0 0 2.00B 0 0
Net Cash Provided by (Used in) Financing Activities -10.30B -17.14B 26.07B -14.83B -9.82B -9.65B

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (PFE CIK 0000078003), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

XRX

XEROX HOLDINGS CORPORATION

EWBC

EAST WEST BANCORP, INC.

OII

OCEANEERING INTERNATIONAL INC